Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001047469-13-002699
Filing Date
2013-03-14
Accepted
2013-03-14 07:39:11
Documents
6

Document Format Files

Seq Description Document Type Size
1 S-3 a2213633zs-3.htm S-3 232844
2 EX-4.11 a2213633zex-4_11.htm EX-4.11 452702
3 EX-4.12 a2213633zex-4_12.htm EX-4.12 459554
4 EX-5.1 a2213633zex-5_1.htm EX-5.1 45257
5 EX-23.1 a2213633zex-23_1.htm EX-23.1 3141
6 G73842KKI001.JPG g73842kki001.jpg GRAPHIC 2636
  Complete submission text file 0001047469-13-002699.txt   1198065
Mailing Address
Business Address 45 HARTWELL AVE LEXINGTON MA 02421 781-274-8200
SYNTA PHARMACEUTICALS CORP (Filer) CIK: 0001157601 (see all company filings)

EIN.: 000000000
Type: S-3 | Act: 33 | File No.: 333-187242 | Film No.: 13689117
SIC: 2834 Pharmaceutical Preparations